Copyright: ©Author(s) 2026.
World J Gastroenterol. Sep 14, 2026; 32(34): 119567
Published online Sep 14, 2026. doi: 10.3748/wjg.v32.i34.119567
Published online Sep 14, 2026. doi: 10.3748/wjg.v32.i34.119567
Table 6 Comparison of therapeutic response of gastric cancer patients in the high and low systemic immune-inflammation index groups, n (%)
| Parameters | Low SII group (n = 128) | High SII group (n = 110) | χ² | P value |
| Disease control rate (PR + SD) | 89 (69.53) | 54 (49.09) | 10.306 | 0.001 |
| PR | 16 (12.50) | 7 (6.36) | ||
| SD | 73 (57.03) | 47 (42.73) | ||
| Progressive disease | 39 (30.47) | 56 (50.91) |
- Citation: Guo R, Gao M. Prognostic value of systemic immune-inflammation index in patients with gastric cancer treated with immune checkpoint inhibitors. World J Gastroenterol 2026; 32(34): 119567
- URL: https://www.wjgnet.com/1007-9327/full/v32/i34/119567.htm
- DOI: https://dx.doi.org/10.3748/wjg.v32.i34.119567